Voriconazole and Sirolimus Coadministration after Allogeneic Hematopoietic Stem Cell Transplantation
Open Access
- 31 May 2006
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 12 (5), 552-559
- https://doi.org/10.1016/j.bbmt.2005.12.032
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Sirolimus‐associated interstitial pneumonitis in solid organ transplant recipientsClinical Transplantation, 2005
- Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantationBone Marrow Transplantation, 2004
- Sirolimus-Associated Diffuse Alveolar HemorrhageMayo Clinic Proceedings, 2004
- Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort studyBlood, 2003
- Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantationBlood, 2003
- Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal InfectionsClinical Infectious Diseases, 2003
- Interaction of Cytochrome P450 3A Inhibitors with P-GlycoproteinJournal of Pharmacology and Experimental Therapeutics, 2002
- Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2002
- Identification of a Novel Route of Extraction of Sirolimus in Human Small Intestine: Roles of Metabolism and SecretionJournal of Pharmacology and Experimental Therapeutics, 2002
- Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International ConsensusClinical Infectious Diseases, 2002